Yes. Electronic prescribing of controlled substances carries strict DEA requirements, including identity-proofing of the prescriber and two-factor authentication at the moment of signing. We help you stand up and maintain the tokens, credentials, and audit logging your EHR and pharmacy network need to stay compliant. We also track the DEA telemedicine flexibilities that allow remote controlled-substance prescribing, which are currently extended only through the end of 2026. Keeping stimulant and psychiatric refills flowing without a compliance gap is part of the service, not an afterthought.